Oncolytic Virus Therapy Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Oncolytic Virus Therapy Market By Application (Melanoma, Lung Cancer, Breast Cancer, Others), By Type (Monoclonal antibodies, Cancer vaccine, Checkpoint inhibitor and Immunomodulators), By End-Users (Hospitals, Specialty Clinics, Cancer Research Institutes), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Oncolytic Virus Therapy Market size was valued at USD 96.5 million in 2021 and is expected to grow at a CAGR of 23.5% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Oncolytic Virus Therapy market, and that can be segmented by application, by type, and by end-user. Oncolytic Virus (OV) Therapy is one of the gifted effective virus therapies used to treat patients suffering from cancer. In a process using OV therapy, the virus infects and disrupts the cancer cell making it useful for other treatments such as chemotherapy. It is also called targeted therapy because OV drugs are injected into the tumor cells directly. The OV therapy market is at a very early stage as clinical trials are ongoing so as to make it beneficial for all types of cancers. It has been positive for breast cancer, melanoma cancer, prostate cancer, and some other cancer diseases. By application, the Oncolytic Virus Therapy market has been segmented into Melanoma, Lung Cancer, Breast Cancer, and Others. The melanoma segment is likely to be the largest and fastest-growing segment in terms of application. The rise of this segment is mainly because most cancer therapies are designed to combat melanoma cancers. There are growing prostate cancer cases also causing a steady progress rate in prostate cancer treatments in recent times.  Based on Type, the Oncolytic Virus Therapy market is segmented into Monoclonal antibodies, Cancer vaccines, Checkpoint inhibitors, and Immunomodulators. Among these, the monoclonal antibodies segment is expected to have a significantly growing market during the forecast period 2022-2028. Based on the End user, the Oncolytic Virus Therapy market is segmented into Smart Hospitals, Specialty Clinics, and Cancer Research Institutes. The hospital segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the existence of skilled staff and accessibility of modern equipment along with the growing number of cancer-affected patients in the hospitals.

Key Developments:

In June 2021, Daiichi Sankyo Co Ltd launched the world’s first oncolytic virotherapy for brain cancer.

In December 2021, Synthetic Biologics acquired VCN Biosciences; the creator of a new oncolytic virus stage targeting pancreatic and other solid tumors.

Oncolytic Virus Therapy Market

MARKET SUMMARY
-
23.5%
  • Study Period– 2022-2028
  • Base Year– 2021
  • CAGR– 23.5%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Oncolytic Virus Therapy Market

  • The oncolytic virus therapy market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • The oncolytic virus therapy market is segmented based on application, type, end-user and geography.
Key Players
  • Amgen
  • Oncolytics Biotech
  • Viralytics
  • Transgene SA
  • Oncolys BioPharma
Oncolytic Virus Therapy Market Drivers

The growing cancer prevalence among citizens and the rising preference for oncolytic virus therapies to treat numerous types of cancer are anticipated to propel the market growth over the forecast years. Moreover, the increasing importance of technological advancement is burgeoning the market growth over the forecast years.


North American Got Significant Share

Oncolytic Virus Therapy Market

North American market is expected to witness the highest market share during the forecast period.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The Oncolytic virus therapy market provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
  • The Oncolytic virus therapy market covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The Oncolytic virus therapy market outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The Oncolytic virus therapy market tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The Oncolytic virus therapy market provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Oncolytic Virus Therapy Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The oncolytic virus therapy market is projected to expand at a CAGR of 23.5% during the forecast period

Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Sorrento Therapeutics, Lokon Pharma,Vyriad, Targovax, SillaJen Biotherapeutics

North American is the fastest-growing region for oncolytic virus therapy market


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Oncolytic Virus Therapy Market Introduction
    • Global Oncolytic Virus Therapy Market – Taxonomy
    • Global Oncolytic Virus Therapy Market –Definitions
      • By Type
      • By Application
      • By End Use
      • By Region
  1. Global Oncolytic Virus Therapy Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Oncolytic Virus Therapy Market Dynamic Factors – Impact Analysis
    • Global Oncolytic Virus Therapy Market – Competition Landscape
  2. Global Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Oncolytic Virus Therapy Market, By Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Monoclonal antibodies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cancer vaccines
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Market Opportunity Analysis
  • Checkpoint inhibitors
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    • Market Opportunity Analysis
  1. Global Oncolytic Virus Therapy Market Forecast, By Application, 2015 – 2019 and Forecast, 2019 – 2025 (Revenue, USD Mn)
    • Melanoma
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Lung Cancer
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Breast Cancer
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Oncolytic Virus Therapy Market Forecast, By End Use, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Market Opportunity Analysis
  • Specialty Clinics
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    • Market Opportunity Analysis
  • Cancer Research Institutes
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    • Market Opportunity Analysis
  1. Global Oncolytic Virus Therapy Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
  • Market Opportunity Analysis
  • Global Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Region, 2020 – 2026
  1. North America Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • USA
      • Canada
    • North America Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • North America Oncolytic Virus Therapy Market Dynamics – Trends

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  1. Europe Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Rest of Europe
    • Europe Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • Europe Oncolytic Virus Therapy Market Dynamics – Trends

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  1. Asia-Pacific Oncolytic Virus Therapy Market Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • Australia & New Zealand
      • Rest of APAC
    • Asia-Pacific Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • Asia-Pacific Oncolytic Virus Therapy Market Dynamics – Trends

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  1. Latin America Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Monoclonal antibodies
      • Cancer vaccines
      • Checkpoint Inhibitors
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Melanoma
      • Lung Cancer
      • Breast Cancer
      • Others
    • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Specialty Clinics
      • Cancer Research Institutes
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Latin America Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
    • Latin America Oncolytic Virus Therapy Market Dynamics – Trends
  2. Middle East and Africa Oncolytic Virus Therapy Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
    • Monoclonal antibodies
    • Cancer vaccines
    • Checkpoint Inhibitors
  • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    • Melanoma
    • Lung Cancer
    • Breast Cancer
    • Others
  • End Use Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
    • Hospitals
    • Specialty Clinics
    • Cancer Research Institutes
  • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
    • GCC Countries
    • Israel
    • South Africa
    • Turkey
    • Rest of MEA
  • MEA Oncolytic Virus Therapy Market – Opportunity Analysis Index, By Type, By Application, By End Use, and Country, 2020 – 2026
  • MEA Oncolytic Virus Therapy Market Dynamics – Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players

Global Oncolytic Virus Therapy Market 2015-2019 and Forecast 2020-2026

  • Company Profiles (Introduction, Financial Analysis, Application & Application Offerings, Key Developments, Strategies, and SWOT Analysis)
    • Amgen
    • Oncolytics Biotech
    • Viralytics
    • Transgene SA
    • Oncolys BioPharma
    • Sorrento Therapeutics
    • Lokon Pharma
    • Vyriad
    • Targovax
    • SillaJen Biotherapeutics
  1. Research Methodology
  2. Key Assumptions and Acronyms

Report

Company Profile

  • Amgen
  • Oncolytics Biotech
  • Viralytics
  • Transgene SA
  • Oncolys BioPharma
  • Sorrento Therapeutics
  • Lokon Pharma
  • Vyriad
  • Targovax
  • SillaJen Biotherapeutics

Description

Oncolytic Virus Therapy Market size was valued at USD 96.5 million in 2021 and is expected to grow at a CAGR of 23.5% during the forecast period 2022 to 2028. The global market provides a detailed overview of the Oncolytic Virus Therapy market, and that can be segmented by application, by type, and by end-user. Oncolytic Virus (OV) Therapy is one of the gifted effective virus therapies used to treat patients suffering from cancer. In a process using OV therapy, the virus infects and disrupts the cancer cell making it useful for other treatments such as chemotherapy. It is also called targeted therapy because OV drugs are injected into the tumor cells directly. The OV therapy market is at a very early stage as clinical trials are ongoing so as to make it beneficial for all types of cancers. It has been positive for breast cancer, melanoma cancer, prostate cancer, and some other cancer diseases. By application, the Oncolytic Virus Therapy market has been segmented into Melanoma, Lung Cancer, Breast Cancer, and Others. The melanoma segment is likely to be the largest and fastest-growing segment in terms of application. The rise of this segment is mainly because most cancer therapies are designed to combat melanoma cancers. There are growing prostate cancer cases also causing a steady progress rate in prostate cancer treatments in recent times.  Based on Type, the Oncolytic Virus Therapy market is segmented into Monoclonal antibodies, Cancer vaccines, Checkpoint inhibitors, and Immunomodulators. Among these, the monoclonal antibodies segment is expected to have a significantly growing market during the forecast period 2022-2028. Based on the End user, the Oncolytic Virus Therapy market is segmented into Smart Hospitals, Specialty Clinics, and Cancer Research Institutes. The hospital segment is expected to have a significant share in 2021. The rise of this segment is mainly because of the existence of skilled staff and accessibility of modern equipment along with the growing number of cancer-affected patients in the hospitals.

Key Developments:

In June 2021, Daiichi Sankyo Co Ltd launched the world’s first oncolytic virotherapy for brain cancer.

In December 2021, Synthetic Biologics acquired VCN Biosciences; the creator of a new oncolytic virus stage targeting pancreatic and other solid tumors.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX